Is Sorafenib available in pharmacies?

The original drug Sorafenib (Sorafenib) has been launched in China and has entered the scope of medical insurance. The reimbursement ratio is different in different regions, and the price after reimbursement may be different. The price of 0.2g*60 tablets may be around 1,200 yuan, and this drug may be sold in domestic pharmacies or hospitals. Sorafenib is a kinase inhibitor used to treat unresectable liver cancer, advanced renal cancer, and differentiated thyroid cancer. Sorafenib reduces tumor cell proliferation in vitro, attenuates tumor growth in human tumor xenografts in immunocompromised mice, reduces tumor angiogenesis, and increases tumor cell apoptosis in hepatocellular carcinoma, renal cell carcinoma, and differentiated thyroid cancer models.